The outlook revision is based on a number of factors, including NMHS’ strong profitability and steady balance sheet.
Fitch also affirmed the “A-” rating on NMHS’ $223.2 million of series 2015 bonds.
More articles on healthcare finance:
William Harris Investors increases stake in CHS as share prices decline
5 hospital CFOs in the headlines
Simcoe Capital Management ups stake in LifePoint
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
